Nutraceutical production guidelines and regulatory bodies worldwide:

Nutraceuticals are used in various of different ways in different countries. Some countries only use them for general health and well-being, while others use them for medicinal purposes. However, to ensure these products' quality, safety, and efficacy and enable their responsible integration into global healthcare systems, it is essential to address the absence of comprehensive regulation. One pivotal part of nutraceutical creation rules is the accentuation of normalizing creation processes¹². Consistent manufacturing practices, such as the use of standardized raw materials, precise formulation methods, and controlled production parameters, are all necessary for this. Nutraceutical products' efficacy and safety depend heavily on product quality, consistency, and reproducibility, which are all made possible by standardization¹³. Nutraceutical producers can maintain the desired therapeutic properties of their products while minimizing variations from batch to batch by adhering to standardized production procedures¹⁴. Most of the world promising countries how they are safeguarding their nutraceuticals production guidelines will be mentioned below,

United States of America:

In the US, nutraceutical products are called dietary supplements. Most dietary supplements have been used for the betterment of health or poor diet of consumers. The Dietary Supplement Health and Education Act (DSHEA) of 1994 passed the regulatory guidelines for those products and specific regulations for each part of the nutraceuticals domain sectors. A product's safety is the manufacturer's responsibility, and laws are upheld through post-market surveillance¹⁵. The Dietary Supplement Health and Education Act (DSHEA) and the FDA's cGMP regulations outline the specific GMP regulations for dietary supplements in the United States¹⁶. The quality, safety, and correct labeling of dietary supplements are the goals of these regulatory bodies in and outside of the USA. Some key requirements will be important for manufacturers or inventors before marketing their product in the USA market¹⁷,

· Measuring the identity, purity, strength, and composition of dietary ingredients as part of quality control¹⁸.

· Establishing written procedures for dietary supplement manufacturing, packaging, labelling, and storage¹⁹.

· Production, testing, and distribution processes are documented and recorded²⁰.

· Proper treatment of product complaints and reports of adverse events²¹.

The Dietary Supplement Health and Education Act (DSHEA) of 1994 and the Code of Federal Regulations (CFR), specifically Title 21, Part 111 (21 CFR Part 111), are the sources of authority for these guidelines. Let's take a look at the most important rules and regulations that manufacturers must follow:

· It is the responsibility of manufacturers to ensure that these regulations are adhered to in their facilities and procedures.

· Employees should receive adequate training to ensure that they are familiar with GMP guidelines and follow them.

· In order to guarantee accurate and consistent production, adequate controls should be in place for the cleaning, maintenance, and calibration of the equipment.

Regulations, such as product recalls, fines, or even legal action, may be taken if GMP requirements are not followed²². Manufacturers boost consumer confidence and well-being by adhering to GMP guidelines and contributing to the nutraceutical industry's overall integrity and credibility²³.

European Union:

The food supplements in the European Union will be directive or ruled by the EU directive. Food regulations will be established throughout the European Union as per the regulated EU directive rules. It will justify the number of domains under food regulation as food raw materials food supplements labeling, packaging, and the quantity of the active ingredients are acceptable or present in the marketed product. The objective of the regulation is to guarantee the efficacy, integrity, and correct labeling of food supplements sold on the EU market. The European Union Department of the European Food Safety Authority (EFSA) will play a unique role in providing any update or evaluation, quality, and safety assessment for food or dietary supplement products²⁴. The scientific evaluation of ingredients used in food supplements, including their bioavailability, safety, and nutrient reference values, is addressed in the EFSA's guidelines. Some key requirements will be important for manufacturers or inventors before marketing their products in the European Union market²⁴.

· Evaluation of food supplements and their ingredients' safety

· Guidelines for risk assessment and ingredient characterization

· Evaluation of dietary supplement health claims

· Requirements for labels, such as declarations of allergens, nutritional information, and ingredient lists²⁵.

Health Canada:

In Canada, natural health products (NHPs), which include nutraceuticals, are governed by Health Canada, the regulatory body in charge. The primary ideal of Health Canada is to guarantee the quality, efficacity, and safety of NHPs available to consumers in Canada. Directorate of Natural and Non-Prescription Health Products (NNHPD) Nutraceuticals and other non-prescription health products fall under the horizon of Health Canada's Natural and Non-prescription Health Products Directorate( NNHPD). The conditions that manufacturers must cleave to misbehave with Good Manufacturing Practices (GMP) are outlined in the NNHPD. Natural health products must meet the GMP conditions for natural health products, Health Canada has established GMP conditions that cover manufacturing, quality control, and safety²⁶. The threat assessment and adverse response monitoring should be required at the bottom level of unit production²⁷. Nutraceuticals and other natural health products are subject to advertising and labeling regulations set by Health Canada. Accurate component lists, lozenge instructions, and exemplary statements must all be included on product markers to meet the specified conditions. To guard consumers' safety and help claims from being deceiving, advertising accoutrements must also cleave to regulations. Health Canada's thing is to ensure that nutraceuticals meet the necessary safety, quality, and efficacity norms for Canadian consumers by administering these regulations²⁸. Some key requirements will be important for manufacturers or inventors before marketing their products in the Health Canada market,

· GMP requirements for natural health products, including facility design and equipment, personnel training, and quality control.

· Ingredient specifications and testing to ensure identity, potency, and purity. Risk assessment and monitoring of adverse reactions.

· Compliance with labelling and advertising regulations²⁹.

Pharmaceuticals and Medical Devices Agency (PMDA) in Japan:

The Pharmaceutical and Medical Devices Agency is the regulatory body of Japan and is responsible for the evaluation and assessment of nutraceuticals dietary supplements, and health products that come under the food category. The PMDA has set the regulatory norms for nutraceuticals or dietary manufacturers for the production process, including the installation of the design of the equipment at the manufacturing place, outfit, labor force, and quality control. These regulations should be followed by each manufacturer if they want to promote their product in the Japanese market³⁰. These guidelines will help the Japan nutraceutical consumers as per their Consumer Protection Act. The manufacturer should submit their evaluation data and scientific process of product manufacturing before marketing their product in their region. The authoritative body of PMDA reviews those data and information for whether the claims are substantiated and biddable with regulations³¹. Some important key requirements will be important for manufacturers or inventors before marketing their product at the PMDA Japan market, there are some important key requirements which will be important for manufactures or inventors before market their product at the PMDA Japan market,

· Standards for manufacturing health foods and functional foods, which encompass nutraceuticals³².

· Requirements for safety, efficacy, and quality control of these products³³.

· Evaluation and approval processes for health claims³⁴.

China Food and Drug Administration (CFDA), now known as the National Medical Products Administration (NMPA):

The China Food and Drug Administration (CFDA), now known as the National Medical Products Administration (NMPA), is the regulatory authority responsible for overseeing the regulation of health foods in China, which includes nutraceuticals³⁵. The Regulations on the Supervision and Administration of Health Foods (SAHF) establish GMP conditions for health food manufacturing in China. These conditions cover colorful aspects, including installation and outfit, labor force, and quality control. The CFDA/ NMPA authorizations product testing and evaluation to ensure the safety and efficacity of nutraceuticals³⁶. Manufacturers are needed to conduct applicable testing and give scientific substantiation to support the safety and efficacity claims of their products. The CFDA/ NMPA has established labeling conditions and advertising regulations for nutraceuticals in China. Advertising must also misbehave with regulations to help deceive claims and ensure consumer safety ³⁷. Some key requirements will be important for manufacturers or inventors before marketing their products at the PMDA Japan market,

· GMP requirements for the production process, including facility and equipment, personnel, and quality control³⁸.

· Product testing and evaluation to ensure safety and efficacy³⁹.

· Labelling requirements and advertising regulations.

Manufacturers and regulatory authorities can learn about best practices, pinpoint areas for potential harmonization and standardization efforts, and enhance the overall quality and safety of nutraceutical products by comparing regional GMP regulations⁴⁰.

Essential components of Good Manufacturing Practice (GMP) for Nutraceuticals product production:

Good Manufacturing Practice (GMP) for nutraceuticals encompasses crucial rudiments that ensure the safety, quality, and efficacity of these products. Raw material sourcing, testing, and control ensure the authenticity and quality of constituents. Manufacturing processes and controls are well-defined, with critical parameters covered for thickness^41,42. Quality control and testing procedures are in place at colorful stages to corroborate product quality. Packaging, labeling, and product shadowing ensure the integrity of the final product. By clinging to these essential factors of GMP, manufacturers can produce nutraceuticals that meet high norms and promote consumer safety and confidence^43,44.

Good Manufacturing Practice (GMP) implementation of nutraceuticals product production:

Enforcing Good Manufacturing Practices (GMP) in nutraceutical products presents unique challenges and considerations. Also, upgrading manufacturing structures to meet GMP norms and establishing comprehensive quality control systems further contribute to the challenges of enforcing GMP in nutraceutical products^45,46. To overcome these challenges and achieve successful perpetration and compliance with GMP, nutraceutical manufacturers can borrow several strategies⁴⁷. First, engage with regulatory experts who retain in-depth knowledge of nutraceutical GMP regulations in target requests. Fourth, apply nonstop enhancement enterprise to enhance manufacturing processes, quality control systems, and threat operation practices. Eventually, establish strong connections with trusted suppliers, apply rigorous supplier qualification and monitoring processes, and regularly assess the quality and trust ability of raw material sources⁴⁸. By addressing these challenges and enforcing effective strategies, nutraceutical manufacturers can navigate the complications of GMP, achieve compliance, and ensure the product of high-quality, safe, and effective nutraceutical products⁴⁹.

Good manufacturing practice (GMP) developments for better consumer health at the industry level:

Advances in Good Manufacturing Practice (GMP) for nutraceutical manufacturing have brought about instigative openings to enhance consumer health through emerging technologies and innovative approaches. Ways like nanoencapsulation, microencapsulation, and spray drying enable bettered delivery systems and enhanced bioavailability of nutraceutical constituents⁵⁰. Advanced extraction methods like supercritical fluid birth and ultrasound-supported extraction optimize the extraction of bioactive composites. Integration of robust quality operation systems, including comprehensive quality control measures and real-time monitoring of critical process parameters, ensures thickness and adherence to GMP norms. The new AI robotization and digitalization technologies streamline manufacturing processes, reduce human error, and enable real-time monitoring of product parameters⁵¹. The quality by Design (QbD) approach proactively designs quality into the manufacturing process, optimizing expression, process parameters, and control strategies⁵². These advancements foster a culture of quality and nonstop enhancement, performing in high-quality, safe, and innovative nutraceutical products that promote consumer health future basis^53,54.

Inspections and Good Manufacturing Practices (GMP) audits at industry level:

GMP check-ups and examinations are vital factors in compliance with Good Manufacturing Practices in nutraceutical goods production⁵⁵. To prepare for examinations, nutraceutical manufacturers should establish robust internal quality operation systems, including bribes, comprehensive attestation, and regular internal check-ups. Best practices include conducting tone- assessments, complete and accessible attestation, enforcing training programs, and cooperating with inspectors during the examination process. By prioritizing routine check-ups and examinations, manufacturers can demonstrate their commitment to GMP compliance, maintain product integrity, and foster consumer trust in the safety and efficacity of nutraceutical products⁵⁶.

Perspectives and suggestions for the future of GMP regulations in the Nutraceutical industry:

Unborn perspectives and recommendations for Nutraceutical GMP involve considering the evolving trends and directions in the assiduity, as well as recommendations for further enhancing product safety and consumer health. To stay ahead in the assiduity, nutraceutical manufacturers should embrace innovative approaches, similar to the use of advanced technologies like artificial intelligence and big data analytics for quality control and monitoring⁵⁷. Also, educating consumers about the significance of choosing GMP guidelines for nutraceutical products and fostering collaboration among regulatory bodies, assiduity associations, and manufacturers are crucial factors for success. Harmonizing GMP regulations encyclopaedically, participating in best practices, and establishing common norms will ensure harmonious product safety and quality. By enforcing these recommendations, nutraceutical assiduity can advance its practices, enhance consumer health and safety, and contribute to the overall well-being of individuals worldwide⁵⁸.

METHOD:

The literature review was conducted to collect applicable data on good manufacturing practices (GMP) in nutraceutical products and identify areas for implicit improvement. The ensuing system was employed. The hunt concentrated on studies and papers published between 2020 and the present, with the end of landing the rearmost exploration and developments in nutraceutical manufacturing practices⁵⁹. The keywords used for the hunt included" nutraceuticals," manufacturing practices," GMP," and affiliated terms. The original webbing of the searched studies involved reviewing titles, objectification, and keywords to identify papers that were directly applicable to the content of enhancing GMP conditions in nutraceutical products. Studies that concentrated on other aspects of nutraceuticals, unconnected manufacturing practices, or weren't published in English were barred. The crucial aspects considered for data birth included the current GMP conditions for nutraceutical products, challenges, and limitations, implicit areas for enhancement, and recommendations from authors or experts in the field. Grounded on the findings from the literature review, specific areas where GMP conditions in nutraceutical products could be enhanced were linked⁶⁰. These areas may include installation design and control, quality operation systems, supplier qualification and raw material testing, process confirmation, labor force training and faculty, traceability and recall procedures, and the integration of advanced technologies. The recommendations and suggestions proposed by authors or experts in the reviewed papers were critically estimated and assessed for feasibility, practicality, and implicit impact on enhancing GMP conditions in nutraceutical products. By synthesizing and assessing the information gathered, this system handed a comprehensive understanding of the current state of GMP practices in nutraceutical products and linked specific areas where conditions can be enhanced to ensure bettered product safety, quality, and compliance⁶¹.

GENERAL DISCUSSION:

Enhancing conditions in nutraceutical production results relative analysis of GMP guidelines In this study, a relative analysis was conducted to assess the current Good Manufacturing Practices (GMP) guidelines applicable to the nutraceutical industry in comparison to the pharmaceutical industry The end was to identify areas where being conditions could be enhanced to ensure advanced safety, quality, and compliance in nutraceutical product. The analysis revealed several notable differences between the GMP guidelines for medicinal and those specific to nutraceuticals⁶². Pharmaceutical GMPs emphasize the need for cleanrooms, controlled surroundings, and outfit confirmation. Enhancing nutraceutical GMP conditions in these areas could ensure better control over manufacturing conditions, reducing the threat of impurity and icing product thickness. Quality management systems: Pharmaceutical GMPs emphasize the perpetration of robust quality operation systems, including comprehensive attestation, quality threat operation, and change control procedures. Incorporating analogous conditions into nutraceutical GMP guidelines would promote better attestation practices, methodical threat assessment, and effective operation of manufacturing process changes. Supplier qualification and raw material testing: Pharmaceutical GMP guidelines place significant emphasis on supplier qualification and raw material testing. Process confirmation: While process confirmation is a well-established practice in the pharmaceutical industry, it is frequently overlooked in nutraceutical manufacturing. Strengthening GMP conditions for nutraceuticals to include process confirmation protocols would help validate the thickness, trust ability, and reproducibility of manufacturing processes, thereby enhancing product quality and safety⁶³. Personnel training and competency: Pharmaceutical GMPs emphasize the need for nonstop training and faculty assessment of the manufacturing labor force. Extending this demand to the nutraceutical industry would ensure that workers are adequately trained in GMP principles, hygiene practices, and quality control procedures, contributing to an advanced position of professionalism and adherence to GMP guidelines. Traceability and recall procedures: The relative analysis stressed the need to enhance traceability and recall procedures in nutraceutical manufacturing. Enforcing further robust systems for batch shadowing, labeling, and recall operation would ameliorate product traceability, grease effective recalls if necessary, and minimize implicit pitfalls to consumer health⁶⁴. The relative analysis of GMP guidelines for medicinal and nutraceuticals revealed several areas where the living conditions in nutraceutical manufacturing could be enhanced⁶⁵. By espousing certain practices from pharmaceutical GMPs, such as installation design and control, quality operation systems, supplier qualification, process confirmation, labor force training, and traceability, nutraceutical manufacturers can enhance their product practices and ensure bettered product quality, safety, and compliance⁶⁶. Enforcing these enhanced GMP conditions would contribute to the overall character of the nutraceutical industry, inspire consumer confidence, and align the industry's manufacturing practices more closely with the strict norms formerly established in the pharmaceutical sector⁶⁷. Likewise, these advancements would foster invention, drive growth, and eventually profit both manufacturers and consumers in the nutraceutical market⁶⁸.

CONCLUSIONS:

Good Manufacturing Practices (GMP) play a vital part in ensuring the quality, safety, and efficacity of nutraceutical products. With the increasing demand for nutraceuticals and the growing complexity of the assiduity, it is essential to enhance the conditions and norms for nutraceutical products. The perpetuation of GMP principles provides a frame that promotes harmonious manufacturing practices, quality control, and nonsupervisory compliance. Comprehensive labeling and product shadowing enable translucency and responsibility, easing traceability and recall procedures if necessary. Likewise, strict quality control and testing procedures are essential to corroborate the safety, efficacity, and compliance of nutraceutical products. Thorough testing of raw materials, in-process samples, and finished products ensures that they meet established specifications and are free from pollutants or contaminations. Regular check-ups and examinations play a vital part in covering GMP compliance, relating areas for enhancement, and icing nonstop adherence to quality norms. To enhance nutraceutical products further, it is pivotal to embrace emerging technologies and inventions that ameliorate effectiveness and safety. Also, by enhancing the conditions and perpetration of GMP in nutraceutical products, manufacturers can meet the growing demand for safe, high-quality, and effective products. Nonstop enhancement, invention, and collaboration among regulatory authorities, assiduity associations, and manufacturers are essential to fostering a culture of excellence in nutraceutical manufacturing. Eventually, a strong commitment to GMP ensures that consumers can confidently choose nutraceuticals that support their health and well-being.

ACKNOWLEDGEMENT:

The authors would like to express their gratitude to the Department of Science and Technology-Fund for Improvement of Science and Technology Infrastructure (DST-FIST), Promotion of University Research and Scientific Excellence (DST-PURSE), and the Department of Biotechnology Boost to University Interdisciplinary Pharmaceutical Regulatory Affairs Science Departments for Education and Research program (DBT-BUILDER) for the facilities provided in our department. Additionally, I thank the following individuals for their expertise and assistance throughout all aspects of my review study and for their help in writing the manuscript. I also extend my heartfelt thanks to JSS Academy of Higher Education, Mysuru, and JSS College of Pharmacy, Ooty, for providing their pool of resources to support and enhance the quality of my review.

AUTHOR CONTRIBUTIONS:

Bishop Adhikari: Conceptualization, Data acquisition, Analysis, Interpretation, Writing-original draft, and Evaluation. D. Nagasamy Venkatesh: Review and editing, Supervision, Critical evaluation, and Validation.

CONFLICT OF INTEREST:

The author is reporting no conflict of interest.

REFERENCES:

1. Chopra AS, Lordan R, Horbańczuk OK, Atanasov AG, Chopra I, Horbańczuk JO, et al. The current use and evolving landscape of nutraceuticals. Pharmacol Res. 2022; 175: 106001.

2. Namdeo Shinde, Bhaskar Bangar, Sunil Deshmukh, Pratik Kumbhar. Nutraceuticals: A Review on current status. Research J. Pharm. and Tech. 2014; 7(1): 110-113.

3. A Rajasekaran, G Sivagnanam, R Xavier. Nutraceuticals as therapeutic agents: A Review. Research J. Pharm. and Tech. 2008; 1(4): 171-174.

4. Sanjay Kumar Jain, Rajesh Kumar Jain. Evolution of GMP in the Pharmaceutical Industry. Research J. Pharm. and Tech. 2017; 10(2): 601-606. doi: 10.5958/0974-360X.2017.00118.4.

5. Anali Sawant, Seema Kamath, Hemanth Katta G, Muddukrishna Badamane Sathyanarayana, Ravindra Shenoy, Girish Pai K . Investigation of manufacturing defects and cGMP lessons learned from quality issues in Pharmaceutical Sterile Preparations. Research Journal of Pharmacy and Technology. 2022; 15(2):729-5. doi: 10.52711/0974-360X.2022.00121.

6. Fabio, P., Alessandro, C., Stefania, S., Iolanda, G., Elena, M., and Aldo, C. The requirements for manufacturing highly active or sensitizing drugs comparing Good Manufacturing Practices. Acta Bio Medica: Atenei Parmensis.2019; 90(2): 288.

7. Allison, G., Cain, Y. T., Cooney, C., Garcia, T., Bizjak, T. G., Holte, O., et al. Regulatory and quality considerations for continuous manufacturing. May 20–21, 2014 continuous manufacturing symposium. Journal of Pharmaceutical Sciences. 2015; 104(3): 803-812.

8. Sarika S. Lokhande. Role of Nutraceuticals in Various Diseases: A Comprehensive Review. Asian J. Pharm. Res. 2018; 8(4): 236-240. doi: 10.5958/2231-5691.2018.00040.0.

9. Sneha Mali, Sanket Rathod, Niraj Kale, Namdeo Shinde. Overview of Nutraceuticals. Asian Journal of Pharmaceutical Research. 2022; 12(1): 61-0. doi: 10.52711/2231-5691.2022.00010.

10. Blanchfield, J. R. Good manufacturing practice (GMP) in the food industry. In Handbook of hygiene control in the food industry. 2005 (pp. 324-347). Woodhead Publishing.

11. Seema Thakur, Neha Srivastava. Nutraceuticals: A Review. Asian J. Res. Pharm. Sci. 2016; 6(2): 85-94. doi: 10.5958/2231-5659.2016.00012.6

12. Burdock, G. A., Carabin, I. G., and Griffiths, J. C. The importance of GRAS to the functional food and nutraceutical industries. Toxicology. 2006; 221(1): 17-27.

13. Kang, J., and Hustvedt, G. Building trust between consumers and corporations: The role of consumer perceptions of transparency and social responsibility. Journal of business ethics. 2014; 125, 253-265.

14. Hock, S. C., Kian, S. M., and Wah, C. L. Global challenges in the manufacture, regulation and international harmonization of GMP and quality standards for biopharmaceuticals. Generics and Biosimilars Initiative Journal. 2020; 9(2): 52-64.

15. Rmmding, F. Tried and True Method. Link: https://naldc.nal.usda.gov/download/IND87016236/pdf.

16. Santini, A., Cammarata, S. M., Capone, G., Ianaro, A., Tenore, G. C., Pani, L., and Novellino, E. Nutraceuticals: Opening the debate for a regulatory framework. British Journal of Clinical Pharmacology. 2018; 84(4): 659-672.

17. Bretaudeau, L., Tremblais, K., Aubrit, F., Meichenin, M., and Arnaud, I. Good manufacturing practice (GMP) compliance for phage therapy medicinal products. Frontiers in Microbiology. 2020; 11, 1161.

18. Bust, L. Importance of documentation in GMP. ISBT Science Series. 2013; 8(1): 16-18.

19. Sikora, T. Good manufacturing practice (GMP) in the production of dietary supplements. In Dietary Supplements. 2015; (pp. 25-36). Woodhead Publishing.

20. DeFelice, S. L. The nutraceutical revolution: its impact on food industry R and D. Trends in Food Science and Technology. 1995; 6(2): 59-61.

21. Keservani, R. K., Kesharwani, R. K., Vyas, N., Jain, S., Raghuvanshi, R., and Sharma, A. K. Nutraceutical and functional food as future food: a review. Der Pharmacia Lettre. 2010; 2(1): 106-116.

22. Kottke, M. K. (1998). Scientific and regulatory aspects of nutraceutical products in the United States. Drug development and industrial pharmacy, 24(12): 1177-1195.

23. Shinde, N., Bangar, B., Deshmukh, S., and Kumbhar, P. Nutraceuticals: A Review on current status. Research Journal of Pharmacy and Techznology. 2014; 7(1): 110-113.

24. Petkova-Gueorguieva, E. S., Getov, I. N., Ivanov, K. V., Ivanova, S. D., Gueorguiev, S. R. et al. Regulatory requirements for food supplements in the European Union and Bulgaria. Folia medica,2019; 61: 37.

25. Silano, V., Coppens, P., Larrañaga-Guetaria, A., Minghetti, P., and Roth-Ehrang, R. Regulations applicable to plant food supplements and related products in the European Union. Food and function. 2011; 2(12): 710-719.

26. Nestmann, E. R., Harwood, M., and Martyres, S. An innovative model for regulating supplement products: natural health products in Canada. Toxicology. 2006; 221(1): 50-58.

27. Fitzpatrick, K. Regulatory issues related to functional foods and natural health products in Canada. Regulation of Functional Foods and Nutraceuticals: A Global Perspective. 2005; 213-226.

28. Smith, A., Jogalekar, S., and Gibson, A. Regulation of natural health products in Canada. Journal of Ethnopharmacology. 2014; 158, 507-510.

29. Harrison, J. R., and Nestmann, E. R. Current Canadian regulatory initiatives and policies for natural health products (dietary supplements). In Nutraceutical and Functional Food Regulations in the United States and Around the World. 2014; (pp. 183-200). Academic Press.

30. Blaze, J. A comparison of current regulatory frameworks for nutraceuticals in Australia, Canada, Japan, and the United States. Innovations in Pharmacy. 2021; 12(2).

31. Daliri, E. B. M., and Lee, B. H. Current trends and future perspectives on functional foods and nutraceuticals. Beneficial microorganisms in food and nutraceuticals. 2015; 221-244.

32. Umegaki, K. Regulatory aspects of nutraceuticals: a Japanese perspective. In Nutraceuticals.2021; (pp. 1299-1307). Academic Press.

33. Mishra, S. S., Behera, P. K., Kar, B., and Ray, R. C. Advances in probiotics, prebiotics and nutraceuticals. Innovations in technologies for fermented food and beverage industries. 2018; 121-141.

34. Chen, J. Regulatory control of Functional Food in China. Scandinavian Journal of Nutrition/Naringsforskning. 2000; 44(3), 130-131.

35. Sun, J. The Regulation of" Novel Food" in China: the Tendency of Deregulation. European Food and Feed Law Review. 2015; 442-448.

36. Huang, G., and Lapsley, K. Chinese health (functional) food regulations. Regulation of Functional Foods and Nutraceuticals: A Global Perspective. 2005; 263-291.

37. Tam, W., and Yang, D. Food safety and the development of regulatory institutions in China. Asian Perspective. 2005; 29(4): 5-36.

38. Chen, K., Wang, X. X., and Song, H. Y. Food safety regulatory systems in Europe and China: A study of how co-regulation can improve regulatory effectiveness. Journal of Integrative Agriculture. 2015; 14(11): 2203-2217.

39. Zawistowski, J. Regulation of functional foods in selected Asian countries in the Pacific rim. In Nutraceutical and Functional Food Regulations in the United States and Around the World.2008; (pp. 365-401). Academic Press.

40. Mtewa, A. G., Chikowe, I., Kumar, S., Ngwira, K. J., and Lampiao, F. Good manufacturing practices and safety issues in functional food industries. Functional Foods and Nutraceuticals: Bioactive Components, Formulations and Innovations.2020; 613-628.

41. Lincoln, J. E. Overview of the US FDA GMPS: Good manufacturing practice (GMP)/quality system (qs) regulation (21 CFR part 820). Journal of Validation Technology. 2021; 18(3): 17.

42. Marucheck, A., Greis, N., Mena, C., and Cai, L. Product safety and security in the global supply chain: Issues, challenges, and research opportunities. Journal of Operations Management. 2011; 29(7-8): 707-720.

43. Ehsan, A. H. Halal Nutraceutical Market: Issues and Challenges. In AFBE 2008 Conference Papers (p. 573).

44. Veeman, M. Policy development for novel foods: issues and challenges for functional food. Canadian Journal of Agricultural Economics/Revue Canadienne d'agroeconomie. 2002; 50(4): 527-539.

45. Gershwin, M. E., Borchers, A. T., Keen, C. L., Hendler, S., Hagie, F., and Greenwood, M. R. C. Public safety and dietary supplementation. Annals of the New York Academy of Sciences. 2010; 1190(1): 104-117.

46. Souto, E. B., Silva, G. F., Dias-Ferreira, J., Zielinska, A., Ventura, F., Durazzo, A., ... and Santini, A. Nanopharmaceutics: Part I—Clinical trials legislation and good manufacturing practices (GMP) of nanotherapeutics in the EU. Pharmaceutics. 2020; 12(2): 146.

47. Dureja, H., Kaushik, D., and Kumar, V. Developments in nutraceuticals. Indian Journal of Pharmacology. 35(6), 363-372.

48. Zeisel, S. H. (1999). Regulation of" nutraceuticals". Science. 2003; 285(5435): 1853-1855.

49. Ochotny, M. N., Partney, T. N., and Pathak, Y. V. Evidence-Based Approach and Standardization of Nutraceuticals. GSTF Journal of Advances in Medical Research (JAMR).2014; 1, 1-3.

50. Puttasiddaiah, R., Lakshminarayana, R., Somashekar, N. L., Gupta, V. K., Inbaraj, B. S., Usmani, Z., et al. Advances in nanofabrication technology for nutraceuticals: New insights and future trends. Bioengineering. 2022; 9(9): 478.

51. Alonso-Alonso, M., Woods, S. C., Pelchat, M., Grigson, P. S., Stice, E., Farooqi, S., ... and Beauchamp, G. K. Food reward system: current perspectives and future research needs. Nutrition reviews.2015; 73(5), 296-307.

52. Wechsler, J. Data integrity key to GMP compliance. BioPharm International. 2014; 27(9).

53. Cicero, A. F., and Rizzo, M. Future Perspectives in Nutraceutical Research. Nutraceuticals and Cardiovascular Disease: An Evidence-based Approach for Clinical Practice. 2021; 289-293.

54. Daliu, P., Santini, A., and Novellino, E. A decade of nutraceutical patents: where are we now in 2018? Expert opinion on therapeutic patents. 2018; 28(12): 875-882.

55. Yang, M. S. Regulatory aspects of nutraceuticals: Chinese perspective. In Nutraceuticals. 2016. (pp. 947-957). Academic Press.

56. He, T. T., Ung, C. O. L., Hu, H., and Wang, Y. T. Good manufacturing practice (GMP) regulation of herbal medicine in comparative research: China GMP, cGMP, WHO-GMP, PIC/S and EU-GMP. European Journal of Integrative Medicine. 2015; 7(1): 55-66.

57. Chahar, D. Natural health products and good manufacturing practices. In Nutraceutical and Functional Food Regulations in the United States and around the World. 2019; (pp. 97-103). Academic Press.

58. Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H. D., and Reinke, P. Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy. 2013; 15(3): 362-383.

59. Huynh‐Ba, K. (2022). Good Manufacturing Practices (GMPs) and Quality Systems. Analytical Testing for the Pharmaceutical GMP Laboratory, 26-56.

60. Awang, D. V. Quality control and good manufacturing practices: Safety and efficacy of commercial herbals. Food and Drug Law Journal. 1997; 52(3): 341-344.

61. Shukla, A., Vishnoi, G., and Das, D. R. Current good manufacturing guidelines for medicinal product. Journal of Drug Delivery and Therapeutics. 2016; 6(2), 57-61.

62. Nelson, K. Facility design. Cell Culture Technology for Pharmaceutical and Cell-Based.2006; 553.

63. Joseph, J. Facility design and process utilities. In Biopharmaceutical Processing. 2018; (pp. 933-986). Elsevier.

64. Patel, K. T., and Chotai, N. P. Documentation and records: harmonized GMP requirements. Journal of Young Pharmacists. 2011; 3(2): 138-150.

65. Roscioli, N. A. N. C. Y., and Vargo, S. U. S. A. N. Facility Design Issues-A Regulatory Perspective. Biotechnology and Bioprocessing Series. 2005; 29: 327.

66. Keservani, R. K., Sharma, A. K., Ahmad, F., and Baig, M. E. Nutraceutical and functional food regulations in India. In Nutraceutical and functional food regulations in the United States and around the world.2014; (pp. 327-342). Academic Press.

67. Sarma, N., Giancaspro, G., and Venema, J. Dietary supplements quality analysis tools from the United States Pharmacopeia. Drug Testing and Analysis. 2016; 8(3-4): 418-423.

68. Jani, U. K. Good manufacturing practices (GMP): “Planning for quality and control in microbiology”. Frontier Discoveries and Innovations in Interdisciplinary Microbiology. 2016; 71-77.

Received on 08.08.2023 Revised on 13.07.2024

Accepted on 05.02.2025 Published on 01.10.2025

Available online from October 04, 2025

Research J. Pharmacy and Technology. 2025;18(10):4990-4998.

DOI: 10.52711/0974-360X.2025.00721

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.

GMP Principles	Application in the Nutraceutical Industry
Quality management system	Establishing robust quality management systems to ensure consistent product quality and safety.
Personnel	Training and qualification programs for staff members to ensure their competence in following GMP guidelines.
Facilities and Equipment	Maintaining clean, controlled environments and using suitable equipment for production and testing processes.
Documentation and Records	Implementing thorough documentation systems to record and track all activities, ensuring traceability and accountability.
Raw material control	Implementing strict protocols for the selection, testing, and approval of raw materials to ensure their quality and safety.
Production and Process Controls	Following standardized procedures to control each stage of production, minimizing risks, and ensuring product consistency.
Packaging and Labelling	Adhering to GMP guidelines for proper packaging and labeling to provide accurate product information and prevent contamination.
Quality Control and Testing	Conducting regular quality control checks and testing to verify product quality, potency, and safety.
Complaints and Product Recall	Establishing procedures to address customer complaints promptly and effectively, including the implementation of product recall measures when necessary.
Regulatory compliance	Ensuring adherence to relevant regulatory requirements and guidelines, including inspections and audits to maintain compliance.

Region	Regulatory Authority	GMP Requirements	Key Regulations and Standards
United States	Food and Drug Administration (FDA)	Current Good Manufacturing Practices (cGMP) for dietary supplements	Facility design and equipment
		Personnel training	Ingredient specifications and testing
		Quality control	Risk assessment and monitoring of adverse reactions
		Labeling requirements and adverse event reporting	Compliance with labeling and advertising regulations
European Union	European Commission	Directive on Food Supplements	Composition, labeling, and purity criteria
European Union	European Commission	European Food Safety Authority (EFSA) guidelines	Harmonization efforts within the EU
Japan	Pharmaceuticals and Medical Devices Agency (PMDA)	Standards for manufacturing healthy foods and functional foods	Requirements for safety, efficacy, and quality control
Japan	Pharmaceuticals and Medical Devices Agency (PMDA)		Evaluation and approval processes for health claims